Bioneer has been an innovative biotechnology company since 1992. Healthy future of humanity with genomic technology. Bioneer was the first Korean biotechnology company when it was founded in 1992. The company has developed state-of-the-art products and technologies for molecular biology, including oligonucleotides, thermostable polymerases, and gene manipulation tools (automatic nucleic acid extractor, thermal cycler, real-time QPCR tools, and DNA sequencer). Since its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully integrate its ability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and tools.

BD (Beckton, Dickinson & Company) is a global medical device and health products company focused on improving drug delivery systems, improving the diagnosis of infectious and oncological diseases, and supporting the development of new drugs. BD develops, manufactures and markets medical devices, devices, laboratory consumables, antibodies, reagents and diagnostic products through three main business units: BD Medical Systems, BD Diagnostic Systems, BD Biotechnology.